查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1989956

體外循環系統市場：全球市場按產品類型、組件、技術、應用和最終用戶分類的預測——2026-2032年

Extracorporeal Circulation System Market by Product Type, Component, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，體外循環系統市場價值將達到 15.8 億美元，到 2026 年將成長到 17 億美元，到 2032 年將達到 27.8 億美元，複合年成長率為 8.36%。

主要市場統計數據
基準年 2025 15.8億美元
預計年份：2026年 17億美元
預測年份 2032 27.8億美元
複合年成長率 (%) 8.36%

本文檔定義了體外循環系統，並概述了影響採購和實施決策的不斷變化的臨床和技術要求。

現代體外循環系統領域，在持續的技術進步和不斷發展的臨床通訊協定的推動下，在心臟外科手術和高級呼吸支持的交叉領域中發揮核心作用。近年來，隨著醫院和專科醫療中心不斷提升其處理複雜心血管手術和嚴重呼吸衰竭的能力，人們對心肺體外迴圈裝置和體外膜氧合（ECMO）平台的關注度日益提高。本文將重點放在臨床促進因素、組件層面的創新以及影響採購和部署決策的政策環境，從而概述此生態系統。

找出正在迅速改變體外循環系統開發和實施的技術進步、臨床實踐演變和監管壓力。

體外循環領域正經歷一場變革，其驅動力來自於泵浦技術、氧合器設計和系統整合方面的創新，以及臨床實踐模式的轉變和監管機構對安全性和實際應用性能的重視。離心式幫浦和磁浮泵因其溶血率低、流量控制更佳而日益普及，而氧合器的進步則側重於氣體交換效率和抗血栓性。這些技術進步催生了新的系統結構，這些架構強調整合解決方案、可攜式平台和一次性組件策略，以降低交叉感染的風險。

了解近期關稅趨勢和貿易政策變化如何影響該行業的採購體系重新評估、成本調整和策略製造應對措施。

2025年美國實施的關稅調整、貿易政策修訂和進口限制的累積影響，將為體外循環生態系統中的製造商、經銷商和終端用戶帶來許多複雜挑戰。進口醫療組件和成品的關稅變化可能會改變接收成本，促使企業重新評估籌資策略，並加速產能轉移和近岸外包。因此，擁有全球供應鏈的企業必須調整其跨國採購慣例，以適應新的關稅環境。

我們按產品、組件、技術、應用和最終用戶進行細分，以確定差異化的臨床需求和產業策略路徑。

精準理解產品細分對於解讀整個體外循環產品系列的研發路徑和臨床相關性至關重要。根據產品類型，該領域包括心肺體外迴圈系統和體外膜氧合（ECMO）平台。心肺體外迴圈解決方案提供整合式和獨立式兩種形式，而ECMO則分別採用靜脈-動脈和靜脈-靜脈模式，以適應不同的心臟和呼吸系統適應症。每類產品都有其獨特的設計、滅菌和臨床培訓要求，這些要求會影響其在醫療機構中的部署模式。

了解美洲、歐洲、中東、非洲和亞太地區在法規、臨床實務和採購模式方面的差異，並將這些差異反映到每個地區的商業化策略中。

區域趨勢對體外循環領域的監管方式、採購行為和臨床實務模式有顯著影響。在美洲，集中化的報銷機制和對實證醫學的重視促使製造商投資於臨床試驗和上市後監測，而醫療服務提供者則優先選擇那些能夠展現出明確營運效益和患者療效的器械。此外，該地區也傾向於與當地分銷商建立策略合作夥伴關係，以便能夠快速回應高優先級醫療中心的需求。

我們評估由系統整合、組件創新、臨床證據的產生以及供應鏈中的策略定位所驅動的競爭差異化。

體外循環系統領域的競爭格局呈現出成熟設備產品組合與專業工程公司快速創新並存的態勢，夥伴關係、收購和共同開發契約已成為常態。老牌製造商憑藉其品牌知名度和全球服務網路，繼續為醫院和專科心臟中心提供產品；而新興參與企業則透過專注於改進泵浦技術、氧合膜以及降低手術複雜性的耗材設計，挑戰現有企業的生存空間。

為製造商和醫療保健系統提供切實可行的策略，以加速採用體外循環系統，增強供應韌性，並加強臨床證據。

體外循環領域的領導企業應採取一系列切實可行的措施，在最大限度地發揮技術優勢的同時，降低營運和政策風險。應優先投資於血液相容性材料、低預充液設計以及模組化架構，以便快速重新配置為靜脈-動脈 (VA) 或靜脈-靜脈 (VV) 支援。這樣做將減輕臨床醫生的負擔，並擴大其在心臟外科手術和呼吸支持等領域的應用範圍。

本文說明了一種多方面的調查方法，該方法結合了對臨床醫生的訪談、技術整合和數據的三角檢驗，從而對醫療設備和臨床實踐的趨勢提供了檢驗的見解。

本執行摘要的調查方法結合了第一手定性研究和全面的二手資料，確保了研究結果的可靠性和可重複性。第一手資料包括對第一線心臟外科醫生和重症監護臨床醫生、醫院和專科診所的採購經理以及醫療設備製造商的高級工程領導進行的結構化訪談。訪談內容主要圍繞臨床工作流程、裝置性能特徵、採購限制以及預期技術進步。

本報告總結了臨床需求、組件創新和政策因素的融合，這些因素將決定體外循環解決方案的可擴展部署。

總之，體外循環領域正邁入一個以系統整合、組件層級改進以及對實證醫學和供應穩定性日益成長的需求為特徵的階段。臨床上對可靠的靜脈-動脈（VA）和靜脈-靜脈（VV）配置的需求，以及對能夠最大限度減少血液負荷並簡化工作流程的泵和氧合器的偏好，持續影響著產品藍圖。同時，政策變化和區域採購趨勢正迫使製造商和供應商重新評估其採購、生產和商業化策略。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 體外循環系統市場：依產品類型分類

  • 心肺體外迴圈系統
    • 整合系統
    • 獨立系統
  • 體外膜氧合（ECMO）
    • VA-ECMO
    • VV-ECMO

第9章 體外循環系統市場：依組件分類

  • 熱交換器
    • 板式熱交換器
    • 管式熱交換器
  • 氧合器
    • 中空纖維氧氣淨化器
    • 膜式氧合器
  • 泵浦
    • 離心式幫浦
    • 磁浮泵浦
    • 滾筒幫浦
  • 管子
    • PVC管
    • 矽膠管

第10章 體外循環系統市場：依技術分類

  • 離心式幫浦
  • 磁浮泵浦
  • 滾筒幫浦

第11章 體外循環系統市場：依應用分類

  • 心臟外科手術
    • 冠狀動脈繞道手術手術
    • 瓣膜置換術
    • 血管外科
  • 呼吸輔助
    • 急性呼吸窘迫症候群
    • 彌合移植差距
    • ECMO治療COVID-19

第12章 體外循環系統市場：依最終用戶分類

  • 門診手術中心
  • 醫院
    • 綜合醫院
    • 心臟科中心
  • 專科診所
    • 兒童醫療中心
    • 研究機構

第13章 體外循環系統市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 體外循環系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 體外循環系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國：體外循環系統市場

第17章 中國：體外循環系統市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Accumed Technologies Inc.
  • Becton Dickinson and Company
  • Beijing Balance Medical Co. Ltd.
  • Braile Biomedica
  • Chalice Medical Ltd.
  • Eurosets Srl
  • Getinge AB
  • Kewei Medical Apparatus Co. Ltd.
  • LivaNova PLC
  • MAQUET Cardiopulmonary AG
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nipro Medical Corporation
  • Senko Medical Instrument Mfg. Co. Ltd.
  • Spectrum Medical Ltd.
  • Terumo Corporation
  • Tianjin Medical Equipment Co. Ltd.
  • Tianjin XinHaoShun Scientific & Trade Co. Ltd.
  • Weigao Group
Product Code: MRR-CD5A9334D17A

The Extracorporeal Circulation System Market was valued at USD 1.58 billion in 2025 and is projected to grow to USD 1.70 billion in 2026, with a CAGR of 8.36%, reaching USD 2.78 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.58 billion
Estimated Year [2026] USD 1.70 billion
Forecast Year [2032] USD 2.78 billion
CAGR (%) 8.36%

Framing the evolving clinical and technological imperatives that define extracorporeal circulation systems and influence procurement and adoption decisions

The contemporary field of extracorporeal circulation systems occupies a central role at the intersection of cardiac surgery and advanced respiratory support, powered by continuous technological refinement and evolving clinical protocols. Recent years have seen intensified focus on both cardiopulmonary bypass equipment and extracorporeal membrane oxygenation platforms as hospitals and specialty centers expand capabilities to manage complex cardiac operations and severe respiratory failure. This introductory overview frames the ecosystem by emphasizing clinical drivers, component-level innovation, and the policy context that shapes procurement and adoption decisions.

Clinicians increasingly demand systems that integrate safety features, ease of priming, and streamlined workflow to reduce operative time and improve patient throughput. Simultaneously, manufacturers pursue miniaturization, improved biocompatibility, and modular architectures that permit rapid configuration for diverse indications. Payers and health systems are pressing for demonstrable clinical value, which elevates the importance of outcomes-based evidence and procedures that shorten intensive care utilization. Therefore, stakeholders should view extracorporeal circulation not simply as hardware, but as a clinical service bundle comprising devices, disposables, training, and post-market support.

Moving forward, decision-makers must weigh clinical effectiveness, operational efficiency, and lifecycle cost while navigating regulatory expectations and supply chain resiliency. In doing so, they can align investments with institutional priorities to enhance patient safety and sustain high-acuity services across care settings.

Identifying the technological advances, clinical practice evolution, and regulatory pressures that are rapidly reshaping extracorporeal circulation system development and adoption

The landscape surrounding extracorporeal circulation is undergoing transformative shifts driven by innovation in pump technologies, oxygenator design, and systems integration, alongside changing clinical practice patterns and regulatory emphasis on safety and real-world performance. Centrifugal and magnetic levitation pumps have gained traction due to reduced hemolysis and improved flow control, while oxygenator advancements focus on gas exchange efficiency and thromboresistance. These engineering improvements enable newer system architectures that favor integrated solutions, portable platforms, and disposable component strategies that lower cross-contamination risk.

Clinical protocols are adapting as extracorporeal membrane oxygenation expands beyond traditional indications. Use in severe respiratory failure and as a bridge to transplant has created demand for flexible venoarterial and venovenous configurations that can be rapidly deployed in intensive care and perioperative environments. In parallel, hospitals emphasize shorter pump run times and faster recovery, which elevates the importance of device ergonomics, rapid setup, and intuitive monitoring interfaces.

Regulatory bodies increasingly require post-market surveillance, clinical data submission, and traceability for critical components. This regulatory tightening encourages manufacturers to invest in quality systems and clinical evidence generation. Additionally, supply chain resilience has ascended as a strategic priority following disruptions, prompting diversification of manufacturing footprints and stronger supplier relationships. Taken together, these forces are pushing the sector toward systems that are safer, more adaptable, and better aligned with contemporary care pathways.

Understanding how recent tariff developments and trade policy shifts contribute to sourcing realignment, cost rebalancing, and strategic manufacturing responses in the sector

The cumulative effect of tariff adjustments, trade policy revisions, and import restrictions implemented in the United States during 2025 introduces a material layer of complexity for manufacturers, distributors, and end users in the extracorporeal circulation ecosystem. Tariff changes on imported medical components and finished devices can alter landed costs, prompt re-evaluation of sourcing strategies, and accelerate relocation or nearshoring of production capabilities. Organizations with global supply chains must therefore reconcile cross-border procurement practices with the new duty environment.

In practice, increased import duties incentivize higher domestic content in assemblies, which can lead to capital investment in local manufacturing or partnerships with U.S.-based contract manufacturers. While such efforts can improve supply reliability and reduce exposure to logistic disruptions, they also require time and capital to qualify alternate suppliers and to ensure regulatory compliance for devices and components. Hospitals and specialty clinics might experience short-term procurement friction as distributors adjust pricing and inventory policies, but they may also benefit from improved vendor transparency and shorter lead times over the medium term.

Policy-driven cost pressures further motivate device makers to accelerate design changes that lower material intensity, enhance modularity, and enable regionalized production. In sum, organizations should anticipate a transition period marked by cost rebalancing, supplier consolidation, and strategic investments aimed at long-term resilience and alignment with the revised trade landscape.

Dissecting product, component, technology, application, and end-user segmentation to reveal differentiated clinical needs and industrial strategic pathways

A nuanced understanding of segmentation is essential to interpret product development pathways and clinical alignment across extracorporeal circulation offerings. Based on product type, the landscape encompasses cardiopulmonary bypass systems and extracorporeal membrane oxygenation platforms; cardiopulmonary bypass solutions present as integrated systems as well as standalone systems, while extracorporeal membrane oxygenation is deployed in venoarterial and venovenous modalities tailored to cardiac and respiratory indications respectively. Each product class imposes distinct engineering, sterilization, and clinical training requirements, which in turn influence adoption patterns across institutions.

Component-level segmentation clarifies technology supply chains and clinical performance trade-offs. Heat exchangers are available as plate and tubular designs with different thermal efficiencies and priming volumes; oxygenators are realized through hollow fiber and membrane constructions that vary in gas exchange properties; pumps include centrifugal, magnetic levitation, and roller formats that drive differences in shear stress and maintenance needs; tubing options span PVC and silicone, each with discrete biocompatibility and handling characteristics. These component choices shape device lifetime, disposables strategies, and clinician preferences.

Technology segmentation further highlights that centrifugal, magnetic levitation, and roller pump approaches each present unique benefits vis-a-vis hemocompatibility, footprint, and integration complexity, thereby guiding R&D investment. Application segmentation distinguishes cardiac surgery indications such as coronary artery bypass grafting, valve replacement, and vascular surgery from respiratory support use cases including acute respiratory distress syndrome, bridge to transplant, and COVID-related ECMO deployment. Finally, end-user segmentation differentiates ambulatory surgery centers with cardiac day surgery workflows, hospitals comprising general and specialized cardiac centers, and specialty clinics such as pediatric centers and research institutes. Together, these intersecting segmentation vectors create a multi-dimensional picture that informs product positioning, service design, and go-to-market strategies.

Mapping divergent regulatory, clinical, and procurement patterns across the Americas, Europe Middle East and Africa, and Asia Pacific to inform regional commercialization strategies

Regional dynamics exert a powerful influence on regulatory approach, procurement behavior, and clinical practice patterns across the extracorporeal circulation domain. In the Americas, centralized reimbursement frameworks and a strong emphasis on evidence-based adoption encourage manufacturers to invest in clinical trials and post-market studies while healthcare providers prioritize devices that demonstrate clear operational and patient outcome benefits. This region also favors strategic partnerships with local distributors to maintain rapid response capabilities for high-acuity centers.

In Europe, Middle East & Africa, regulatory environments vary considerably, prompting manufacturers to maintain flexible regulatory and market access teams that can navigate divergent approval pathways and reimbursement regimes. Clinical preferences often reflect a balance between cost containment and the adoption of advanced technology, which spurs modular solutions that can be tailored by facility capability. Supply chain fragmentation across the region incentivizes partnerships with regional logistics specialists and local service providers to ensure continuity of consumables and maintenance.

Across Asia-Pacific, rapid capacity expansion of specialty hospitals and increasing investment in tertiary cardiac and respiratory programs are driving demand for both integrated systems and component supplies. Regulatory modernization and rising clinical expertise support adoption of advanced pump and oxygenator technologies, while domestic manufacturing in several countries contributes to competitive pricing dynamics. Stakeholders should therefore adopt region-specific strategies that align product configurations, training programs, and service models with local clinical workflows and procurement practices.

Evaluating competitive differentiation driven by systems integration, component innovation, clinical evidence generation, and supply chain strategic positioning

Competitive dynamics within extracorporeal circulation systems combine legacy device portfolios with rapid innovation from specialized engineering firms, creating a landscape in which partnerships, acquisitions, and co-development agreements are common. Established manufacturers continue to leverage brand recognition and global service networks to supply hospitals and specialized cardiac centers, while emerging entrants challenge incumbents through focused improvements in pump technology, oxygenator membranes, and disposable consumable design that reduce procedural complexity.

Strategic differentiation increasingly centers on systems integration, clinician training services, and digital monitoring capabilities that provide real-time performance data and enable preventive maintenance. Companies that invest in end-to-end solutions-comprising hardware, disposables, software-enabled analytics, and education programs-tend to secure longer-term relationships with health systems. At the same time, component suppliers that offer low-volume customization and rapid prototyping are attractive partners for original equipment manufacturers seeking to accelerate product enhancements.

Supply chain control is another axis of competition; firms that maintain diversified manufacturing footprints and deep supplier relationships for critical materials are better positioned to manage disruptions and tariff impacts. Regulatory expertise and a robust clinical evidence base further amplify competitive advantage, as payers and provider procurement teams increasingly favor suppliers who can demonstrate outcomes and support across the product lifecycle.

Actionable strategies for manufacturers and health systems to accelerate adoption, build supply resilience, and strengthen clinical evidence supporting extracorporeal systems

Leaders in the extracorporeal circulation space should adopt a set of pragmatic actions to capitalize on technological momentum while mitigating operational and policy risks. Prioritize investments in hemocompatible materials, low-prime-volume designs, and modular architectures that enable rapid reconfiguration for venoarterial or venovenous support. By doing so, manufacturers can reduce clinician burden and broaden the addressable clinical use cases across cardiac surgery and respiratory support.

Concurrently, develop regional manufacturing and packaging strategies to mitigate tariff exposure and improve lead times. Establishing validated partnerships with contract manufacturers in key geographies or enhancing domestic assembly capabilities will reduce supply fragility. Complementing these moves with robust inventory planning and multi-sourcing for critical components will further insulate operations from disruption.

Strengthen clinical evidence generation through targeted registries and pragmatic clinical studies focused on outcomes such as hemolysis rates, oxygenation efficiency, and device-related complication reduction. Invest in clinician training programs and simulation-based curricula to accelerate safe adoption and to build preference for your systems. Finally, engage proactively with regulators and payers to align product labeling, reimbursement coding, and post-market surveillance expectations, which will smooth market access and support longer-term commercial sustainability.

Explaining the multi-source research approach that combines clinician interviews, technical synthesis, and data triangulation to deliver validated insights into device and clinical practice dynamics

The research methodology underpinning this executive summary integrates a blend of primary qualitative inquiry and comprehensive secondary source synthesis to ensure robust, reproducible insights. Primary inputs included structured interviews with practicing cardiac and critical care clinicians, procurement executives from hospitals and specialty clinics, and senior engineering leaders within device firms. These conversations focused on clinical workflows, device performance attributes, procurement constraints, and anticipated technology trajectories.

Secondary research encompassed regulatory filings, peer-reviewed clinical literature, device technical specifications, and policy documents to validate technical claims and to contextualize regional regulatory differences. Data triangulation techniques were applied to reconcile divergent viewpoints and to identify consistent patterns across clinical settings and geographies. The analysis also incorporated component-level technical comparison to illuminate trade-offs between pump types, oxygenator constructions, and material choices.

Quality assurance included cross-validation of key findings with independent clinical advisors and iterative review cycles to refine interpretations. Limitations pertain to rapidly evolving clinical practice and potential variability in local procurement policies; nonetheless, the methodological approach prioritizes transparency and traceability to support confident decision-making by stakeholders.

Summarizing the convergence of clinical demand, component innovation, and policy drivers that will determine the scalable adoption of extracorporeal circulation solutions

In conclusion, the extracorporeal circulation domain is transitioning to a phase characterized by integrated systems, component-level refinement, and heightened expectations for evidence and supply resilience. Clinical demand for reliable venoarterial and venovenous configurations, coupled with preferences for pumps and oxygenators that minimize blood trauma and streamline workflows, continues to shape product roadmaps. At the same time, policy changes and regional procurement dynamics compel manufacturers and providers to reassess sourcing, manufacturing, and commercialization strategies.

Stakeholders who align product design with clinician needs, invest in demonstrable clinical outcomes, and build flexible supply networks will secure competitive advantage while enhancing patient safety and institutional readiness for complex cardiac and respiratory cases. The interplay between technological innovation, regulatory diligence, and operational execution will determine which solutions scale effectively across diverse care settings, from ambulatory cardiac day surgery facilities to tertiary referral centers and specialized pediatric programs.

Overall, a strategic focus on modularity, evidence generation, and regional alignment will enable durable adoption of extracorporeal circulation capabilities that meet contemporary clinical and organizational imperatives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Extracorporeal Circulation System Market, by Product Type

  • 8.1. Cardiopulmonary Bypass System
    • 8.1.1. Integrated Systems
    • 8.1.2. Standalone Systems
  • 8.2. Extracorporeal Membrane Oxygenation
    • 8.2.1. Venoarterial Ecmo
    • 8.2.2. Venovenous Ecmo

9. Extracorporeal Circulation System Market, by Component

  • 9.1. Heat Exchanger
    • 9.1.1. Plate Heat Exchanger
    • 9.1.2. Tubular Heat Exchanger
  • 9.2. Oxygenator
    • 9.2.1. Hollow Fiber Oxygenator
    • 9.2.2. Membrane Oxygenator
  • 9.3. Pump
    • 9.3.1. Centrifugal Pump
    • 9.3.2. Magnetic Levitation Pump
    • 9.3.3. Roller Pump
  • 9.4. Tubing
    • 9.4.1. Pvc Tubing
    • 9.4.2. Silicone Tubing

10. Extracorporeal Circulation System Market, by Technology

  • 10.1. Centrifugal Pump
  • 10.2. Magnetic Levitation Pump
  • 10.3. Roller Pump

11. Extracorporeal Circulation System Market, by Application

  • 11.1. Cardiac Surgery
    • 11.1.1. Coronary Artery Bypass Grafting
    • 11.1.2. Valve Replacement
    • 11.1.3. Vascular Surgery
  • 11.2. Respiratory Support
    • 11.2.1. Acute Respiratory Distress Syndrome
    • 11.2.2. Bridge To Transplant
    • 11.2.3. Covid Ecmo

12. Extracorporeal Circulation System Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Hospitals
    • 12.2.1. General Hospitals
    • 12.2.2. Specialized Cardiac Centers
  • 12.3. Specialty Clinics
    • 12.3.1. Pediatric Centers
    • 12.3.2. Research Institutes

13. Extracorporeal Circulation System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Extracorporeal Circulation System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Extracorporeal Circulation System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Extracorporeal Circulation System Market

17. China Extracorporeal Circulation System Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Accumed Technologies Inc.
  • 18.6. Becton Dickinson and Company
  • 18.7. Beijing Balance Medical Co. Ltd.
  • 18.8. Braile Biomedica
  • 18.9. Chalice Medical Ltd.
  • 18.10. Eurosets S.r.l.
  • 18.11. Getinge AB
  • 18.12. Kewei Medical Apparatus Co. Ltd.
  • 18.13. LivaNova PLC
  • 18.14. MAQUET Cardiopulmonary AG
  • 18.15. Medtronic plc
  • 18.16. MicroPort Scientific Corporation
  • 18.17. Nipro Medical Corporation
  • 18.18. Senko Medical Instrument Mfg. Co. Ltd.
  • 18.19. Spectrum Medical Ltd.
  • 18.20. Terumo Corporation
  • 18.21. Tianjin Medical Equipment Co. Ltd.
  • 18.22. Tianjin XinHaoShun Scientific & Trade Co. Ltd.
  • 18.23. Weigao Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOARTERIAL ECMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOARTERIAL ECMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOVENOUS ECMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VENOVENOUS ECMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PLATE HEAT EXCHANGER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PLATE HEAT EXCHANGER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PLATE HEAT EXCHANGER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBULAR HEAT EXCHANGER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBULAR HEAT EXCHANGER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBULAR HEAT EXCHANGER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOLLOW FIBER OXYGENATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOLLOW FIBER OXYGENATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOLLOW FIBER OXYGENATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MEMBRANE OXYGENATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MEMBRANE OXYGENATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MEMBRANE OXYGENATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PVC TUBING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PVC TUBING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PVC TUBING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SILICONE TUBING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SILICONE TUBING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SILICONE TUBING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CENTRIFUGAL PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY MAGNETIC LEVITATION PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ROLLER PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VALVE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VALVE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VALVE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY VASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COVID ECMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COVID ECMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COVID ECMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PEDIATRIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PEDIATRIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PEDIATRIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 257. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 274. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 275. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 277. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 278. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 279. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEAT EXCHANGER, 2018-2032 (USD MILLION)
  • TABLE 280. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATOR, 2018-2032 (USD MILLION)
  • TABLE 281. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 282. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 283. GCC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)

TABLE 2